Plato Investment Management LTD Royalty Pharma PLC Transaction History
Plato Investment Management LTD
- $1.36 Trillion
- Q4 2024
A detailed history of Plato Investment Management LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Plato Investment Management LTD holds 6,503 shares of RPRX stock, worth $217,070. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,503
Previous 38,310
83.03%
Holding current value
$217,070
Previous $1.08 Billion
84.62%
% of portfolio
0.01%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$768 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$566 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...